Last update 23 Jan 2025

Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd

Joint Venture Company | Private Company|
2017|
Zhejiang Sheng, China

Overview

Related

1
Drugs associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
NB001(Yongzhan Pharmaceutical)
Target
ADCY1
Mechanism
ADCY1 inhibitors [+1]
Active Org.
University of TorontoUniversity of Toronto
Originator Org.
Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
Active Indication
Neuralgia
Inactive Indication
Cancer Pain
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
CTR20180859
/ CompletedPhase 1
评估NB001在国人健康成年受试者中的安全性、耐受性、药代动力学和进食对药代动力学影响的I期临床试验
[Translation] Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and the effect of food on pharmacokinetics of NB001 in healthy adult Chinese subjects
100 Clinical Results associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
Login to view more data
0 Patents (Medical) associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
Login to view more data
100 Deals associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Zhejiang Yongzhan Pharmaceutical Technology Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
NB001(Yongzhan Pharmaceutical)
 ( ADCY1 )		Cancer Pain
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free